What FDA Taylor Farms lettuce false positive means
Packages of Taylor Farms salad greens are displayed at a Safeway store on July 16, 2026 in Kings Beach, California....
HEALTH & FITNESS
Market for psychedelic drugs to treat mental health gets a buy signal
Psilocybin mushrooms stand ready for harvest in a humidified "fruiting chamber." John Moore | Getty ImagesThursday's announcement that Eli Lilly...
Ozempic for cats? GLP-1 weight-loss drugs are coming for your fat pet
A beautiful, but over weight Maine Coon Cat gets measured around the belly by a vet.Ryersonclark | E+ | Getty...
Trump rips Canada for wildfire smoke, threatens tariffs boost
Smoke from massive wildfires in Canada engulf the New York City skyline, reducing visibility and casting an orange haze over...
Cyclosporiasis outbreak linked to Taco Bell may not have major impact
Customers enter a Taco Bell restaurant on July 14, 2026 in La Cañada Flintridge, California. Mario Tama | Getty ImagesThe...
Spain’s Deoleo says market has entered a new phase
Jaen city and surrounding Olive groves and trees, Jaen is known as the Olive Oil capital producing around 25% of...
This stock’s next growth phase is taking shape
Danaher is a classic compounder waking from a pandemic-era destocking cycle that pressured profits. With bioprocessing demand beginning to recover,...
3 of our stocks rode the AI rally, while 3 others fell out of favor since last month
The stock market continued its march higher since our last CNBC Investing Club Monthly Meeting, though the leadership shifted beneath...
Eli Lilly to buy psychedelics maker AtaiBeckley for $2.8 billion
The Eli Lilly logo appears on the company’s office in San Diego, California, Nov. 21, 2025.Mike Blake | ReutersEli Lilly...
J&J falls despite a beat-and-raise quarter. Why we’re raising our price target anyways
Johnson & Johnson shares fell Tuesday despite a mostly strong second-quarter earnings report and an increase to its full-year guidance....
Biotech’s recovery isn’t a ‘head fake.’ These 3 stocks could lead the next leg up
The stock market's attention has been focused almost exclusively on artificial intelligence, semiconductors and a handful of megacap technology companies....
AstraZeneca’s trial flop raises bigger questions around its pipeline
AstraZeneca's failed late-stage trial for Wainua was never expected to have a major financial impact on the company.Most analysts estimate...
Abivax $920 million cash haul lets it prepare for U.S. launch: CEO
Abivax's latest funding round allows the biotech to move toward a U.S. launch of its bowel disease drug without backing...
Employers aren’t expanding coverage of GLP-1 obesity drugs: survey
A version of this article first appeared in CNBC's Healthy Returns newsletter, which brings the latest health-care news straight to...
Jim Cramer says these are the 5 stocks to buy during this market rotation
CNBC's Jim Cramer said Monday that investors shouldn't fear the latest market rotation. Instead, he thinks it's creating buying opportunities...
Experts say USAID closure made virus harder to contain
Doctors Without Borders health workers wearing personal protective equipment move through the isolated red zone to monitor patients, provide medical...
Jim Cramer says this former Covid market darling is finally investable again
Moderna's expanding pipeline beyond infectious diseases is giving investors a new reason to own the stock after years of uncertainty...
Walmart, CVS step in to help seniors
A version of this article first appeared in CNBC's Healthy Returns newsletter, which brings the latest health-care news straight to...
Cramer says this stock is significantly undervalued, sees 35% upside
Every weekday, the CNBC Investing Club with Jim Cramer holds a "Morning Meeting" livestream at 10:20 a.m. ET. Here's a...
FDA allows Philip Morris-owned Zyn marketed as less harmful cigarettes
In this photo illustration, Zyn nicotine cases are seen on a table on Jan. 29, 2024, in New York City.Michael...
